JHS Sven.Lab.

JHS02 May 2024

FMCG

₹

+0.24 (+1.29%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in JHS Sven.Lab.

JHS Sven.Lab.

FMCG

JHS02 May 2024

₹

+0.24 (+1.29%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-Nov-2011	D	JHS Svendgaard Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 28, 2011, inter alia, has recommended the payment of Final dividend of Rs. 0.75/- (Rupees Seventy Five Paise only) per equity share of the face value of Rs.10/- each for the financial year ended March 31, 2011 and has adjourned the Board Meeting to December 02, 2011, inter alia, to consider and take on record the Audited Financial Results for the financial year ended on March 31, 2011.	26-Dec-2011
31-May-2010	D	JHS Svendgaard Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2010, has recommended payment of Final Dividend of Rs. 0.50/- (Rupees Fifty Paise only), per equity share of the face value of Rs. 10/- each for the financial year ended March 31, 2010.	22-Dec-2010
01-Jul-2009	D	JHS Svendgaard Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2009, inter alia, has recommended a dividend of Rs 0.25 per share on Equity Shares for the financial year 2008-09.	10-Sep-2009
05-Feb-2024	BC	JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. The Un-Audited Financial Re	14-Feb-2024
07-Feb-2024	BC	Trading members of the Exchange are hereby informed that the under mentioned new securities of JHS Svendgaard Laboratories Limited (Scrip Code: 532771) are listed and permitted for trading on the Exc	08-Feb-2024
17-Feb-2024	BC	Sixth Sense India Opportunities II (Sale Dated on: 08/02/2024 to 16/02/2024)	08-Feb-2024
30-Jan-2024	BC	Sixth Sense India Opportunities-II	26-Jan-2024
31-Jan-2024	BC	Nikhil Nanda, Sushma Nanda, Daljit Singh Grewal and Harish Chander Nanda	26-Jan-2024

No Rights has been declared by JHS

Book Closure

Record Date	Split Date	Purpose
14-Feb-2024	-	JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. The Un-Audited Financial Re
08-Feb-2024	-	Trading members of the Exchange are hereby informed that the under mentioned new securities of JHS Svendgaard Laboratories Limited (Scrip Code: 532771) are listed and permitted for trading on the Exc
08-Feb-2024	-	Sixth Sense India Opportunities II (Sale Dated on: 08/02/2024 to 16/02/2024)
26-Jan-2024	-	Sixth Sense India Opportunities-II
26-Jan-2024	-	Nikhil Nanda, Sushma Nanda, Daljit Singh Grewal and Harish Chander Nanda

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
JHS Svendgaard Laboratories Ltd ₹18.90(+0.24/1.29%)	18.90	+0.24	146.29	5.66	24.88	0.85
Colgate-Palmolive (India) Ltd ₹2,850.90(+26.20/0.93%)	2,850.90	+26.20	76,827.78	79.45	60.23	43.57
Nestle India Ltd ₹2,538.95(+32.90/1.31%)	2,538.95	+32.90	241,622.61	15.31	75.78	72.32
Foods & Inns Ltd ₹156.50(-0.85/-0.54%)	156.50	-0.85	893.18	10.07	19.31	2.31
Britannia Industries Ltd ₹4,811.95(+41.35/0.87%)	4,811.95	+41.35	114,908.63	5.79	54.40	46.70
Hindustan Unilever Ltd ₹2,241.65(+10.95/0.49%)	2,241.65	+10.95	524,123.32	-9.00	51.48	10.28

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	14.30	18.93	15.90	20.60	22.19	21.05
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	14.30	18.93	15.90	20.60	22.19	21.05
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.34	0.20	0.41	7.58	0.94	2.52
Total Income	16.64	19.13	16.31	28.18	23.13	23.57
Total Expenditure	14.36	18.52	18.03	42.59	24.41	23.02
PBIDT	2.28	0.60	-1.72	-14.41	-1.28	0.55
Interest	0.11	0.10	0.13	0.08	0.16	0.12
PBDT	2.18	0.51	-1.84	-14.49	-1.44	0.43
Depreciation	1.63	1.50	1.32	1.57	1.46	1.49
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.54	-0.26	-0.58	-6.62	-0.14	-0.14
Reported Profit After Tax	0.01	-0.73	-2.59	-9.44	-2.76	-0.92
Extra-ordinary Items	0.00	0.00	0.00	-18.63	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.01	-0.73	-2.59	9.19	-2.76	-0.92

EPS (Unit Curr.)	0.00	-0.09	-0.33	-1.45	-0.35	-0.12
EPS (Adj) (Unit Curr.)	0.00	-0.09	-0.33	-1.43	-0.35	-0.12
Calculated EPS (Unit Curr.)	0.00	-0.09	-0.33	-1.45	-0.35	-0.12
Calculated EPS (Adj) (Unit Curr.)	0.00	-0.09	-0.33	-1.43	-0.35	-0.12
Calculated EPS (Ann.) (Unit Curr.)	0.01	-0.37	-1.32	-5.82	-1.41	-0.47
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.01	-0.37	-1.30	-5.75	-1.39	-0.46
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	78.40	78.40	78.40	64.90	78.40	78.40
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	15.94	3.17	-10.82	-69.95	-5.77	2.61
PBDTM(%)	15.24	2.69	-11.57	-70.34	-6.49	2.04
PATM(%)	0.07	-3.86	-16.29	-45.83	-12.44	-4.37

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	14.30	18.93	15.90	25.40	22.19	21.05
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	14.30	18.93	15.90	25.40	22.19	21.05
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.34	0.20	0.41	7.81	0.94	2.52
Total Income	16.64	19.13	16.31	33.21	23.13	23.57
Total Expenditure	14.36	18.52	18.03	46.88	24.41	23.02
PBIDT	2.28	0.60	-1.72	-13.67	-1.28	0.55
Interest	0.11	0.10	0.13	0.39	0.16	0.12
PBDT	2.17	0.51	-1.84	-14.06	-1.44	0.43
Depreciation	1.63	1.50	1.32	2.31	1.46	1.49
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.13	0.00	0.00
Deferred Tax	0.54	-0.26	-0.58	-6.37	-0.14	-0.14
Reported Profit After Tax	0.01	-0.73	-2.59	-10.13	-2.76	-0.92
Minority Interest After NP	0.00	0.00	0.00	-0.25	0.00	0.00
Net Profit after Minority Interest	0.01	-0.73	-2.59	-9.87	-2.76	-0.92

Extra-ordinary Items	0.00	0.00	0.00	-18.50	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.01	-0.73	-2.59	8.63	-2.76	-0.92

EPS (Unit Curr.)	0.00	-0.09	-0.33	-1.52	-0.24	-0.11
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	78.40	78.40	78.40	64.90	64.90	78.40

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	15.94	3.17	-10.82	-53.82	-5.77	2.61
PBDTM(%)	15.17	2.69	-11.57	-55.35	-6.49	2.04
PATM(%)	0.07	-3.86	-16.29	-39.88	-12.44	-4.37

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	64.90	64.90	64.40	60.90	60.90	60.90
Reserves Total	109.92	124.87	126.83	120.60	119.09	115.74
Equity Share Warrants	0.00	0.00	0.25	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	174.82	189.77	191.48	181.50	179.99	176.64
Secured Loans	0.23	0.37	0.33	0.66	5.92	1.36
Unsecured Loans	1.55	1.80	2.14	1.90	1.10	1.10
Total Debt	1.78	2.17	2.47	2.56	7.02	2.46
Total Liabilities	176.60	191.94	193.95	184.06	187.01	179.10
APPLICATION OF FUNDS :
Gross Block	99.73	86.10	84.00	77.56	88.87	84.24
Less : Accumulated Depreciation	36.12	30.70	25.32	19.73	19.76	12.95
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	63.61	55.40	58.68	57.83	69.11	71.29
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	4.44	15.83	8.85	6.98	4.74	0.42
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	16.18	15.39	14.21	16.52	15.36	18.20
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	10.87	9.25	9.19	3.65	8.52	9.18
Sundry Debtors	18.18	16.19	58.69	95.31	56.08	42.66
Cash and Bank	34.04	5.48	16.88	0.51	0.60	5.89
Loans and Advances	43.11	53.91	17.19	13.73	27.24	23.02
Total Current Assets	106.19	84.83	101.94	113.20	92.44	80.76
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	34.04	16.01	19.10	42.24	30.34	25.04
Provisions	0.13	0.32	0.61	2.23	1.49	0.58
Total Current Liabilities	34.17	16.33	19.72	44.47	31.83	25.61
Net Current Assets	72.02	68.50	82.23	68.73	60.61	55.15
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	11.37	7.22	10.36	11.11	12.05	12.74
Deferred Tax Liability	4.66	4.53	4.25	3.46	6.41	6.88
Net Deferred Tax	6.71	2.69	6.11	7.65	5.64	5.86
Total Assets	162.95	157.82	170.09	157.71	155.46	150.92
Contingent Liabilities	1.97	7.15	2.63	2.73	2.52	2.21

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	64.90	64.90	64.40	60.90	60.90	60.90
Reserves Total	107.53	121.00	124.05	117.10	115.71	113.36
Equity Share Warrants	0.00	0.00	0.25	0.00	0.23	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	172.43	185.90	188.70	178.00	176.84	174.26
Minority Interest	7.87	9.14	9.27	6.60	3.79	-0.10
Secured Loans	0.38	0.69	0.74	0.74	5.99	1.39
Unsecured Loans	3.09	5.50	6.27	7.84	1.20	1.10
Total Debt	3.47	6.19	7.01	8.58	7.19	2.49
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	15.76	2.98	1.36	1.22	1.03	0.83
Total Liabilities	199.53	204.21	206.34	194.40	188.85	177.48
APPLICATION OF FUNDS :
Gross Block	103.60	90.24	92.30	87.05	90.69	84.36
Less: Accumulated Depreciation	37.40	31.72	29.08	21.41	19.87	12.95
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	66.20	58.52	63.22	65.64	70.82	71.41
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	8.57	19.96	8.92	7.05	4.80	0.51
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	4.12	3.62	2.05	6.03	9.75	18.19
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	13.64	12.21	12.11	6.15	10.40	10.04
Sundry Debtors	20.67	18.12	58.71	96.15	53.81	42.73
Cash and Bank	39.69	6.46	21.15	0.93	1.07	6.31
Loans and Advances	14.79	39.83	27.41	21.51	33.11	25.96
Total Current Assets	88.79	76.62	119.38	124.74	98.40	85.04
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	36.54	17.57	21.48	44.81	32.21	30.27
Provisions	0.13	0.32	0.62	2.24	1.50	0.58
Total Current Liabilities	36.66	17.89	22.10	47.05	33.71	30.85
Net Current Assets	52.13	58.73	97.29	77.69	64.69	54.19
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	16.05	12.18	14.33	15.30	14.85	13.31
Deferred Tax Liability	4.37	5.07	3.80	3.99	6.54	6.77
Net Deferred Tax	11.68	7.11	10.53	11.31	8.31	6.54
Other Assets	56.84	56.28	24.34	26.70	30.51	26.64
Total Assets
Contingent Liabilities	2.02	7.19	2.63	3.18	2.63	2.21

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	5.48	16.53	0.27	0.34	5.52
Net Cash from Operating Activities	20.21	-11.28	15.42	15.14	-10.10
Net Cash Used In Investing Activities	9.14	-0.96	-5.58	-6.76	1.22
Net Cash Used In Financing Activities	-0.79	0.02	6.42	-8.45	3.71
Net Inc./Dec In Cash And Cash Equivalents	28.56	-12.22	16.26	-0.07	-5.18
Cash And Cash Equivalents At End Of The Year	34.04	4.31	16.53	0.27	0.34

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

37.73%

FII Shareholding

2.30%

DII Shareholding

0.00%

Public Shareholding

53.76%

**Promoter pledged shareholding 37.73%

About JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd is in the FMCG sector, having a market capitalization of Rs. 146.29 crores. It has reported a sales of Rs. 14.3 crores and a net profit of Rs. 0.01 crores for the quarter ended December 2018. The company management includes Rajagopal Chakravarthi, Nikhil Nanda.,Mukul Pathak,Rohina Sanjay Sangtani,Rajagopal Chakravarthi,Kapil Minocha,Vinay Mittal,Komal,Upma Chawdhry (JHS Svendgaard Laboratories Ltd) among others.

Chairman

Rajagopal Chakravarthi

Registered office

Trilokpur Road Kheri(Kala Amb),Tehsil Nahan District,Sirmour,Himachal Pradesh,173030

FAX :91-1702-238831

Background

Incorporation Year2004

Face Value₹10

Market Lot1

How to buy JHS Sven.Lab. shares on nse?

To buy JHS Sven.Lab. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the JHS Sven.Lab. share price today?

The JHS Sven.Lab. shares price on nse is Rs.18.9 today.

What is the market cap of JHS Sven.Lab. shares on BSE ?

The company has a market capitalization of Rs.146.29Cr

What is the PE & PB ratio of JHS Sven.Lab. shares ?

PE is 24.88 and PB is 0.85

What is the 52 Week High and Low of JHS Sven.Lab. shares?

JHS Sven.Lab. stock price high: Rs.39.45 JHS Sven.Lab. stock price low: Rs.14.81